Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 3 (NDUFB3) is an accessory subunit of mitochondrial respiratory chain Complex I, the largest of the five enzyme complexes in the electron transport chain. It is located in the inner mitochondrial membrane as a single-pass membrane protein, helping anchor Complex I and maintain its structural integrity. While it is not directly involved in electron catalysis, NDUFB3 is critical for complex assembly and function. It facilitates the initial transfer of electrons from NADH to coenzyme Q10, enabling ATP generation by oxidative phosphorylation. Mutations in NDUFB3 have clinical significance, being implicated in mitochondrial complex I deficiency and associated with disorders of oxidative phosphorylation. Altered NDUFB3 expression is also relevant in diseases such as cancer, where it can affect mitochondrial reactive oxygen species production and influence tumor progression and patient prognosis[1][2][4].
Modulation of electron transport chain activity; regulation of mitochondrial reactive oxygen species production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 3 (NDUFB3).